Measuring Global Health: Difference between revisions
Wendy Walker (talk | contribs) No edit summary |
Wendy Walker (talk | contribs) No edit summary |
||
| Line 32: | Line 32: | ||
It produced estimates of mortality and morbidity by age, sex and region. | It produced estimates of mortality and morbidity by age, sex and region. | ||
The ongoing Global Burden of Disease Study<ref name="GBD 2015">GBD 201 Mortality and Causes of Death Collaborators. The Lancet, 8 Oct 2016, Vol 388, No 10053, p1459-1544</ref> is described as "The most comprehensive worldwide observational epidemiological study to date." It describes mortality and morbidity from disease and injury. It quantifies global, regional and national life expectancy, all-cause mortality and cause specific mrtality for 249 causes of death, 1980-2015. | The ongoing Global Burden of Disease Study<ref name="GBD 2015">GBD 201 Mortality and Causes of Death Collaborators. The Lancet, 8 Oct 2016, Vol 388, No 10053, p1459-1544</ref> is described as "The most comprehensive worldwide observational epidemiological study to date." It describes mortality and morbidity from disease and injury. It quantifies global, regional and national life expectancy, all-cause mortality and cause specific mrtality for 249 causes of death, 1980-2015. It is led by the Institute for Health Metrics and Evaluation (HME), University of Washington, USA, and researchers are based throughout the world: there are more than 1,000 researchers from more than 100 countries, which includes 26 low and middle-income countries. | ||
As well as examining 249 causes of death, it reviews 315 disease and injuries and 79 risk factors. The data is taken from 195 countries and territories between 1990 and 2015. | As well as examining 249 causes of death, it reviews 315 disease and injuries and 79 risk factors. The data is taken from 195 countries and territories between 1990 and 2015. | ||
== Summary == | == Summary == | ||
Revision as of 00:28, 13 December 2016
Original Editor - Your name will be added here if you created the original content for this page.
Top Contributors - Wendy Walker, Rachael Lowe, Naomi O'Reilly, Kim Jackson, Jess Bell, Admin, Tarina van der Stockt, Franca Ebomah and Laura Ritchie
Introduction[edit | edit source]
Measuring global health is frequently defined in terms of measurement of the Global Disease Burden [GBD] which is defined as the impact of a health problem as measure by mortality, morbidity and financial cost.
When comparing GBD data from different countries, there is a marked difference between nations which are developed to a greater or lesser degree.
Units of Measurement[edit | edit source]
There are a number of measurements which can be used to measure global health.
The 3 main units of measurement are the "ALYs":
The DALY (Disability-Adjusted Life Year) is frequently used as a measure of disease burden.
The World Health Organisation (WHO) use DALY measurements to compare the overall health and life expectancy of various countries.
The QALY (Quality-Adjusted Life Year) is a measure of disease burden which accounts for both the health-related quality of life a person is predicted to experience, and the length of life expectancy.
The HALY (Health-Adjusted Life Year) includes DALYs and QALYs in order to describe morbidity and mortality rates with a single number.
Halys are often used to estimate the burden of disease and compare the impact of specific diseases/health conditions on communities.
Global Burden of Disease (GBD) project[edit | edit source]
The first Global Burden of Disease [GBD] study reported the health effects of more than 100 diseases and injuries in 8 regions of the world in the year 1990.
It produced estimates of mortality and morbidity by age, sex and region.
The ongoing Global Burden of Disease Study[1] is described as "The most comprehensive worldwide observational epidemiological study to date." It describes mortality and morbidity from disease and injury. It quantifies global, regional and national life expectancy, all-cause mortality and cause specific mrtality for 249 causes of death, 1980-2015. It is led by the Institute for Health Metrics and Evaluation (HME), University of Washington, USA, and researchers are based throughout the world: there are more than 1,000 researchers from more than 100 countries, which includes 26 low and middle-income countries.
As well as examining 249 causes of death, it reviews 315 disease and injuries and 79 risk factors. The data is taken from 195 countries and territories between 1990 and 2015.
Summary[edit | edit source]
Resources[edit | edit source]
A summary of the most recent GBD study findings, 2015 in The Lancet.
Recent Related Research (from Pubmed)[edit | edit source]
Extension:RSS -- Error: Not a valid URL: Feed goes here!!|charset=UTF-8|short|max=10
References[edit | edit source]
References will automatically be added here, see adding references tutorial.
- ↑ GBD 201 Mortality and Causes of Death Collaborators. The Lancet, 8 Oct 2016, Vol 388, No 10053, p1459-1544
